{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:36:44Z","timestamp":1793644604786,"version":"4.5.1"},"reference-count":189,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,5]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Cancer cachexia is a multi-organ syndrome and closely related to changes in signal communication between organs, which is mediated by cancer cachexia factors. Cancer cachexia factors, being the general name of inflammatory factors, circulating proteins, metabolites, and microRNA secreted by tumor or host cells, play a role in secretory or other organs and mediate complex signal communication between organs during cancer cachexia. Cancer cachexia factors are also a potential target for the diagnosis and treatment. The pathogenesis of cachexia is unclear and no clear effective treatment is available. Thus, the treatment of cancer cachexia from the perspective of the tumor ecosystem rather than from the perspective of a single molecule and a single organ is urgently needed. From the point of signal communication between organs mediated by cancer cachexia factors, finding a deeper understanding of the pathogenesis, diagnosis, and treatment of cancer cachexia is of great significance to improve the level of diagnosis and treatment. This review begins with cancer cachexia factors released during the interaction between tumor and host cells, and provides a comprehensive summary of the pathogenesis, diagnosis, and treatment for cancer cachexia, along with a particular sight on multi-organ signal communication mediated by cancer cachexia factors. This summary aims to deepen medical community's understanding of cancer cachexia and may conduce to the discovery of new diagnostic and therapeutic targets for cancer cachexia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000002846","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T03:00:09Z","timestamp":1700103609000},"page":"44-62","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":26,"title":["Cancer cachexia: Focus on cachexia factors and inter-organ communication"],"prefix":"10.1097","volume":"137","author":[{"given":"Yongfei","family":"Wang","sequence":"first","affiliation":[{"name":"The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu 730000, China"},{"name":"Institute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu 730000, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zikai","family":"Dong","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu 730000, China"},{"name":"Institute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu 730000, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"An","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu 730000, China"},{"name":"Institute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu 730000, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilin","family":"Jin","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu 730000, China"},{"name":"Institute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu 730000, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"R1-20250602","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) \"cachexia-anorexia in chronic wasting diseases\" and \"nutrition in geriatrics\"","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin Nutr"},{"key":"R2-20250602","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: Effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"R3-20250602","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00520-012-1697-z","article-title":"Diagnostic criteria of cancer cachexia: Relation to quality of life, exercise capacity and survival in unselected palliative care patients","volume":"21","author":"Wallengren","year":"2013","journal-title":"Support Care Cancer"},{"key":"R4-20250602","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"R5-20250602","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"R6-20250602","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41571-023-00734-5","article-title":"Cancer-associated cachexia\u2013Understanding the tumour macroenvironment and microenvironment to improve management","volume":"20","author":"Argil\u00e9s","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"R7-20250602","doi-asserted-by":"crossref","first-page":"960341","DOI":"10.3389\/fcell.2022.960341","article-title":"Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene","volume":"10","author":"Ferrara","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R8-20250602","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1038\/s41598-020-64282-z","article-title":"An elevated neutrophil-to-lymphocyte ratio associates with weight loss and cachexia in cancer","volume":"10","author":"Barker","year":"2020","journal-title":"Sci Rep"},{"key":"R9-20250602","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.lfs.2010.11.011","article-title":"Identification of serum proteins involved in pancreatic cancer cachexia","volume":"88","author":"Felix","year":"2011","journal-title":"Life Sci"},{"key":"R10-20250602","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MCO.0b013e328351c3fc","article-title":"TWEAK and TRAF6 regulate skeletal muscle atrophy","volume":"15","author":"Kumar","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R11-20250602","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/SPC.0b013e328359e6dd","article-title":"Muscle protein kinetics in cancer cachexia","volume":"6","author":"Johns","year":"2012","journal-title":"Curr Opin Support Palliat Care"},{"key":"R12-20250602","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/jcsm.12346","article-title":"Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice","volume":"9","author":"Kandarian","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R13-20250602","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1096\/fj.201701465RR","article-title":"The tumor secretory factor ZAG promotes white adipose tissue browning and energy wasting","volume":"32","author":"Elattar","year":"2018","journal-title":"FASEB J"},{"key":"R14-20250602","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41467-017-00726-x","article-title":"Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat Commun"},{"key":"R15-20250602","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41598-017-02347-2","article-title":"Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"R16-20250602","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/jcsm.12851","article-title":"Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole","volume":"13","author":"Liu","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R17-20250602","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cmet.2015.11.003","article-title":"PTH\/PTHrP receptor mediates cachexia in models of kidney failure and cancer","volume":"23","author":"Kir","year":"2016","journal-title":"Cell Metab"},{"key":"R18-20250602","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/jcsm.12008","article-title":"Differences in food intake of tumour-bearing cachectic mice are associated with hypothalamic serotonin signalling","volume":"6","author":"Dwarkasing","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R19-20250602","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuropharm.2017.12.024","article-title":"Brainstem GLP-1 signalling contributes to cancer anorexia-cachexia syndrome in the rat","volume":"131","author":"Borner","year":"2018","journal-title":"Neuropharmacology"},{"key":"R20-20250602","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1038\/ncomms5859","article-title":"Hypothalamic S1P\/S1PR1 axis controls energy homeostasis","volume":"5","author":"Silva","year":"2014","journal-title":"Nat Commun"},{"key":"R21-20250602","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41556-020-00628-z","article-title":"Tumour-derived Dilp8\/INSL3 induces cancer anorexia by regulating feeding neuropeptides via Lgr3\/8 in the brain","volume":"23","author":"Yeom","year":"2021","journal-title":"Nat Cell Biol"},{"key":"R22-20250602","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1042\/BST20180213","article-title":"Emerging role of extracellular vesicles in mediating cancer cachexia","volume":"46","author":"Chitti","year":"2018","journal-title":"Biochem Soc Trans"},{"key":"R23-20250602","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jcsm.12844","article-title":"Extracellular vesicles derived from tumour cells as a trigger of energy crisis in the skeletal muscle","volume":"13","author":"Pin","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R24-20250602","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12943-018-0899-5","article-title":"Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression","volume":"17","author":"Wu","year":"2018","journal-title":"Mol Cancer"},{"key":"R25-20250602","first-page":"974","article-title":"IGFBP-3 promotes cachexia-associated lipid loss by suppressing insulin-like growth factor\/insulin signaling","volume":"136","author":"Wang","year":"2023","journal-title":"Chin Med J"},{"key":"R26-20250602","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3390\/ijms22041565","article-title":"The role of tumor microenvironment cells in colorectal cancer (CRC) cachexia","volume":"22","author":"Kasprzak","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R27-20250602","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3389\/fonc.2019.01146","article-title":"Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy","volume":"9","author":"Masucci","year":"2019","journal-title":"Front Oncol"},{"key":"R28-20250602","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","article-title":"Muscle-organ crosstalk: The emerging roles of myokines","volume":"41","author":"Severinsen","year":"2020","journal-title":"Endocrine Rev"},{"key":"R29-20250602","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3389\/fneur.2018.00698","article-title":"Endocrine crosstalk between skeletal muscle and the brain","volume":"9","author":"Delezie","year":"2018","journal-title":"Front Neurol"},{"key":"R30-20250602","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/japplphysiol.00080.2007","article-title":"Role of myokines in exercise and metabolism","volume":"103","author":"Pedersen","year":"2007","journal-title":"J Appl Physiol"},{"key":"R31-20250602","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s13539-011-0049-z","article-title":"Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance","volume":"3","author":"Busquets","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R32-20250602","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/15384101.2016.1259037","article-title":"STAT3-mediated SMAD3 activation underlies oncostatin M-induced senescence","volume":"16","author":"Bryson","year":"2017","journal-title":"Cell Cycle"},{"key":"R33-20250602","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.yjmcc.2018.07.250","article-title":"Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway","volume":"121","author":"Li","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"R34-20250602","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12020-018-1814-y","article-title":"The novel myokine irisin: Clinical implications and potential role as a biomarker for sarcopenia in postmenopausal women","volume":"64","author":"Park","year":"2019","journal-title":"Endocrine"},{"key":"R35-20250602","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1186\/s12885-015-1898-1","article-title":"Serum irisin levels are lower in patients with breast cancer: Association with disease diagnosis and tumor characteristics","volume":"15","author":"Provatopoulou","year":"2015","journal-title":"BMC Cancer"},{"key":"R36-20250602","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","article-title":"A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis","volume":"481","author":"Bostr\u00f6m","year":"2012","journal-title":"Nature"},{"key":"R37-20250602","first-page":"3727","article-title":"Is irisin a decisive protein in cancer cachexia and death of cancer cells?","volume":"20","author":"Aydin","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R38-20250602","doi-asserted-by":"crossref","first-page":"188761","DOI":"10.1016\/j.bbcan.2022.188761","article-title":"Muscle-to-tumor crosstalk: The effect of exercise-induced myokine on cancer progression","volume":"1877","author":"Huang","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R39-20250602","doi-asserted-by":"crossref","first-page":"8260742","DOI":"10.1155\/2018\/8260742","article-title":"Myokines as possible therapeutic targets in cancer cachexia","volume":"2018","author":"Manole","year":"2018","journal-title":"J Immunol Res"},{"key":"R40-20250602","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/cam4.231","article-title":"Decreased decorin expression in the tumor microenvironment","volume":"3","author":"Bozoky","year":"2014","journal-title":"Cancer Med"},{"key":"R41-20250602","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ctrv.2010.12.001","article-title":"Anti-cancer role of SPARC, an inhibitor of adipogenesis","volume":"37","author":"Nagaraju","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"R42-20250602","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/pros.22664","article-title":"Exogenous SPARC suppresses proliferation and migration of prostate cancer by interacting with integrin \u03b21","volume":"73","author":"Shin","year":"2013","journal-title":"Prostate"},{"key":"R43-20250602","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.drup.2008.08.005","article-title":"SPARC in cancer biology: Its role in cancer progression and potential for therapy","volume":"11","author":"Tai","year":"2008","journal-title":"Drug Resist Updat"},{"key":"R44-20250602","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/gutjnl-2011-300776","article-title":"A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise","volume":"62","author":"Aoi","year":"2013","journal-title":"Gut"},{"key":"R45-20250602","doi-asserted-by":"crossref","first-page":"16042","DOI":"10.1073\/pnas.1514250112","article-title":"Musclin is an activity-stimulated myokine that enhances physical endurance","volume":"112","author":"Subbotina","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R46-20250602","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3390\/cancers11101541","article-title":"Musclin, A myokine induced by aerobic exercise, retards muscle atrophy during cancer cachexia in mice","volume":"11","author":"Re Cecconi","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R47-20250602","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1085-9489.2005.10307.x","article-title":"Different expressions of BDNF, NT3, and NT4 in muscle and nerve after various types of peripheral nerve injuries","volume":"10","author":"Omura","year":"2005","journal-title":"J Peripher Nerv Syst"},{"key":"R48-20250602","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1091\/mbc.e10-02-0154","article-title":"Brain-derived neurotrophic factor regulates satellite cell differentiation and skeltal muscle regeneration","volume":"21","author":"Clow","year":"2010","journal-title":"Mol Biol Cell"},{"key":"R49-20250602","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1016\/j.jprot.2012.06.037","article-title":"Muscle tissue as an endocrine organ: Comparative secretome profiling of slow-oxidative and fast-glycolytic rat muscle explants and its variation with exercise","volume":"75","author":"Roca-Rivada","year":"2012","journal-title":"J Proteomics"},{"key":"R50-20250602","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3389\/fphys.2019.01188","article-title":"Examination of the myokine response in pregnant and non-pregnant women following an acute bout of moderate-intensity walking","volume":"10","author":"Hutchinson","year":"2019","journal-title":"Front Physiol"},{"key":"R51-20250602","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.clnu.2020.10.050","article-title":"Myokines in treatment-na\u00efve patients with cancer-associated cachexia","volume":"40","author":"de Castro","year":"2021","journal-title":"Clin Nutr"},{"key":"R52-20250602","doi-asserted-by":"crossref","first-page":"32802","DOI":"10.1074\/jbc.M803440200","article-title":"Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism","volume":"283","author":"Ouchi","year":"2008","journal-title":"J Biol Chem"},{"key":"R53-20250602","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/mus.23893","article-title":"A differential pattern of gene expression in skeletal muscle of tumor-bearing rats reveals dysregulation of excitation\u2013contraction coupling together with additional muscle alterations","volume":"49","author":"Fontes-Oliveira","year":"2014","journal-title":"Muscle Nerve"},{"key":"R54-20250602","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1054\/bjoc.2000.1299","article-title":"Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats","volume":"83","author":"Carb\u00f3","year":"2000","journal-title":"Br J Cancer"},{"key":"R55-20250602","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1177\/15353702211009213","article-title":"Role of myokines and osteokines in cancer cachexia","volume":"246","author":"Pin","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"key":"R56-20250602","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.semcdb.2016.02.009","article-title":"STAT3 in the systemic inflammation of cancer cachexia","volume":"54","author":"Zimmers","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"R57-20250602","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat Rev"},{"key":"R58-20250602","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","article-title":"Inter-tissue communication in cancer cachexia","volume":"15","author":"Argil\u00e9s","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"R59-20250602","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s11010-022-04398-0","article-title":"The burning furnace: Alteration in lipid metabolism in cancer-associated cachexia","volume":"477","author":"Joshi","year":"2022","journal-title":"Mol Cell Biochem"},{"key":"R60-20250602","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00041433-200312000-00003","article-title":"Obesity, adiponectin and vascular inflammatory disease","volume":"14","author":"Ouchi","year":"2003","journal-title":"Curr Opinion Lipidol"},{"key":"R61-20250602","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.3390\/ijms22063110","article-title":"Aerobic exercise ameliorates cancer cachexia-induced muscle wasting through adiponectin signaling","volume":"22","author":"Morinaga","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R62-20250602","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.tem.2007.10.006","article-title":"Location, location: Protein trafficking and lipolysis in adipocytes","volume":"19","author":"Granneman","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"R63-20250602","doi-asserted-by":"crossref","first-page":"24665","DOI":"10.1074\/jbc.273.38.24665","article-title":"Overexpression of perilipin A and B blocks the ability of tumor necrosis factor alpha to increase lipolysis in 3T3-L1 adipocytes","volume":"273","author":"Souza","year":"1998","journal-title":"J Biol Chem"},{"key":"R64-20250602","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbrc.2004.04.010","article-title":"Targets for TNF-alpha-induced lipolysis in human adipocytes","volume":"318","author":"Ryd\u00e9n","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"R65-20250602","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1194\/jlr.M600471-JLR200","article-title":"NF-kappaB is important for TNF-alpha-induced lipolysis in human adipocytes","volume":"48","author":"Laurencikiene","year":"2007","journal-title":"J Lipid Res"},{"key":"R66-20250602","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cellimm.2007.09.004","article-title":"Leptin beyond body weight regulation \u2013 Current concepts concerning its role in immune function and inflammation","volume":"252","author":"Lago","year":"2008","journal-title":"Cell Immunol"},{"key":"R67-20250602","doi-asserted-by":"crossref","first-page":"287457","DOI":"10.1155\/2012\/287457","article-title":"Leptin in anorexia and cachexia syndrome","volume":"2012","author":"Engineer","year":"2012","journal-title":"Int J Peptides"},{"key":"R68-20250602","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000108280","article-title":"Regulation of food intake by inflammatory cytokines in the brain","volume":"86","author":"Buchanan","year":"2007","journal-title":"Neuroendocrinology"},{"key":"R69-20250602","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3945\/ajcn.2008.27273","article-title":"A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: Contributions of organ and tumor mass to whole-body energy demands","volume":"89","author":"Lieffers","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"R70-20250602","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature24042","article-title":"Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15","volume":"550","author":"Hsu","year":"2017","journal-title":"Nature"},{"key":"R71-20250602","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41574-021-00529-7","article-title":"GDF15: Emerging biology and therapeutic applications for obesity and cardiometabolic disease","volume":"17","author":"Wang","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"R72-20250602","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nature05484","article-title":"Gut hormones and the regulation of energy homeostasis","volume":"444","author":"Murphy","year":"2006","journal-title":"Nature"},{"key":"R73-20250602","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","article-title":"Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice","volume":"26","author":"Suriben","year":"2020","journal-title":"Nat Med"},{"key":"R74-20250602","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev-pharmtox-032322-093904","article-title":"Fibroblast growth factor-based pharmacotherapies for the treatment of obesity-related metabolic complications","volume":"63","author":"Jin","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R75-20250602","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1097\/CM9.0000000000001890","article-title":"The role of FGF21 in the pathogenesis of cardiovascular disease","volume":"134","author":"Zhang","year":"2021","journal-title":"Chin Med J."},{"key":"R76-20250602","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fendo.2014.00107","article-title":"FGF21 as a Hepatokine, adipokine, and myokine in metabolism and diseases","volume":"5","author":"Itoh","year":"2014","journal-title":"Front Endocrinol"},{"key":"R77-20250602","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/jcsm.12409","article-title":"Fibroblast growth factor 21 controls mitophagy and muscle mass","volume":"10","author":"Oost","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R78-20250602","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mam.2019.07.005","article-title":"Switching on the furnace: Regulation of heat production in brown adipose tissue","volume":"68","author":"Li","year":"2019","journal-title":"Mol Aspects Med"},{"key":"R79-20250602","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nut.2018.11.004","article-title":"Higher serum levels of fibroblast growth factor 21 in old patients with cachexia","volume":"63\u201364","author":"Franz","year":"2019","journal-title":"Nutrition"},{"key":"R80-20250602","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1677\/erc.1.01239","article-title":"Human melanoma cells express functional receptors for thyroid-stimulating hormone","volume":"13","author":"Ellerhorst","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"R81-20250602","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ncpendmet0677","article-title":"Antagonists of growth-hormone-releasing hormone: An emerging new therapy for cancer","volume":"4","author":"Schally","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"R82-20250602","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1124\/pr.57.4.1","article-title":"International union of pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function","volume":"57","author":"Davenport","year":"2005","journal-title":"Pharmacol Rev"},{"key":"R83-20250602","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/gast.2001.22158","article-title":"Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin","volume":"120","author":"Asakawa","year":"2001","journal-title":"Gastroenterology"},{"key":"R84-20250602","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0304-3940(03)00789-4","article-title":"Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats","volume":"349","author":"Yasuda","year":"2003","journal-title":"Neurosci Lett"},{"key":"R85-20250602","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1172\/JCI200421134","article-title":"Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells","volume":"114","author":"Dixit","year":"2004","journal-title":"J Clin Invest"},{"key":"R86-20250602","first-page":"611","article-title":"Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice","volume":"123","author":"Porporato","year":"2013","journal-title":"J Clin Invest"},{"key":"R87-20250602","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2265.2008.03321.x","article-title":"Ghrelin and the differential regulation of des-acyl (DSG) and oct-anoyl ghrelin (OTG) in human adipose tissue (AT)","volume":"70","author":"Kos","year":"2009","journal-title":"Clin Endocrinol"},{"key":"R88-20250602","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature21697","article-title":"MC4R-dependent suppression of appetite by bone-derived lipocalin 2","volume":"543","author":"Mosialou","year":"2017","journal-title":"Nature"},{"key":"R89-20250602","doi-asserted-by":"crossref","first-page":"14589","DOI":"10.1038\/s41598-020-71249-7","article-title":"Lipocalin-2 deficiency may predispose to the progression of spontaneous age-related adiposity in mice","volume":"10","author":"Meyers","year":"2020","journal-title":"Sci Rep"},{"key":"R90-20250602","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mce.2015.10.017","article-title":"Muscle-bone interactions: From experimental models to the clinic? A critical update","volume":"432","author":"Laurent","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"R91-20250602","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nm.3961","article-title":"Excess TGF-\u03b2 mediates muscle weakness associated with bone metastases in mice","volume":"21","author":"Waning","year":"2015","journal-title":"Nat Med"},{"key":"R92-20250602","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3390\/cancers14040963","article-title":"Early neutrophilia marked by aerobic glycolysis sustains host metabolism and delays cancer cachexia","volume":"14","author":"Petruzzelli","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R93-20250602","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.4049\/jimmunol.1302895","article-title":"Novel role for tumor-induced expansion of myeloid-derived cells in cancer cachexia","volume":"192","author":"Cuenca","year":"2014","journal-title":"J Immunol (Baltimore)"},{"key":"R94-20250602","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature19084","article-title":"Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion","volume":"536","author":"Sousa","year":"2016","journal-title":"Nature"},{"key":"R95-20250602","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00011-022-01586-y","article-title":"Cancer- and cardiac-induced cachexia: Same fate through different inflammatory mediators?","volume":"71","author":"Nogueira-Ferreira","year":"2022","journal-title":"Inflamm Res"},{"key":"R96-20250602","doi-asserted-by":"crossref","first-page":"17441","DOI":"10.1074\/jbc.RA120.014884","article-title":"Methylarginine metabolites are associated with attenuated muscle protein synthesis in cancer-associated muscle wasting","volume":"295","author":"Kunz","year":"2020","journal-title":"J Biol Chem"},{"key":"R97-20250602","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/ijc.27494","article-title":"Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia","volume":"131","author":"Springer","year":"2012","journal-title":"Int J Cancer"},{"key":"R98-20250602","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1021\/acs.jproteome.9b00088","article-title":"Metabolic profiling of tumors, sera, and skeletal muscles from an orthotopic murine model of gastric cancer associated-cachexia","volume":"18","author":"Cui","year":"2019","journal-title":"J Proteome Res"},{"key":"R99-20250602","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/metabo9090178","article-title":"Multiplatform urinary metabolomics profiling to discriminate cachectic from non-cachectic colorectal cancer patients: Pilot results from the ColoCare study","volume":"9","author":"Ose","year":"2019","journal-title":"Metabolites"},{"key":"R100-20250602","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/metabo11060404","article-title":"A time-course comparison of skeletal muscle metabolomic alterations in walker-256 tumour-bearing rats at different stages of life","volume":"11","author":"Chiocchetti","year":"2021","journal-title":"Metabolites"},{"key":"R101-20250602","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.cell.2023.03.028","article-title":"Cachexia: A systemic consequence of progressive, unresolved disease","volume":"186","author":"Ferrer","year":"2023","journal-title":"Cell"},{"key":"R102-20250602","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.physbeh.2010.03.011","article-title":"Hypothalamic mechanisms in cachexia","volume":"100","author":"Grossberg","year":"2010","journal-title":"Physiol Behav"},{"key":"R103-20250602","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20111020","article-title":"Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis","volume":"208","author":"Braun","year":"2011","journal-title":"J Exp Med"},{"key":"R104-20250602","doi-asserted-by":"crossref","first-page":"E785","DOI":"10.1152\/ajpendo.00646.2007","article-title":"The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene","volume":"295","author":"Waddell","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R105-20250602","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cmet.2011.01.001","article-title":"Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle","volume":"13","author":"Shimizu","year":"2011","journal-title":"Cell Metab"},{"key":"R106-20250602","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jcsm.12528","article-title":"Cancer cachexia and its pathophysiology: Links with sarcopenia, anorexia and asthenia","volume":"11","author":"Peixoto da Silva","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R107-20250602","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MCO.0000000000000401","article-title":"The role of hypothalamic inflammation, the hypothalamic-pituitary-adrenal axis and serotonin in the cancer anorexia-cachexia syndrome","volume":"20","author":"van Norren","year":"2017","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R108-20250602","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13539-012-0065-7","article-title":"Hypogonadism in male cancer patients","volume":"3","author":"Burney","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R109-20250602","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/SPC.0000000000000061","article-title":"The assessment and management of cancer cachexia: Hypogonadism and hypermetabolism among supportive and palliative care patients","volume":"8","author":"Dev","year":"2014","journal-title":"Curr Opin Support Palliat Care"},{"key":"R110-20250602","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/cncr.28619","article-title":"Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer","volume":"120","author":"Dev","year":"2014","journal-title":"Cancer"},{"key":"R111-20250602","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.cell.2019.07.033","article-title":"GDF15 is an inflammation-induced central mediator of tissue tolerance","volume":"178","author":"Luan","year":"2019","journal-title":"Cell"},{"key":"R112-20250602","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcsm.12033","article-title":"Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients","volume":"6","author":"Lerner","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R113-20250602","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jcsm.12077","article-title":"MAP3K11\/GDF15 axis is a critical driver of cancer cachexia","volume":"7","author":"Lerner","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R114-20250602","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.clnu.2018.09.023","article-title":"Liver lipid metabolism disruption in cancer cachexia is aggravated by cla supplementation -induced inflammation","volume":"38","author":"Gon\u00e7alves","year":"2019","journal-title":"Clin Nutr"},{"key":"R115-20250602","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/BF01121584","article-title":"Sympathetic activation of brown-adipose-tissue thermogenesis in cachexia","volume":"1","author":"Brooks","year":"1981","journal-title":"Biosci Rep"},{"key":"R116-20250602","first-page":"2405","article-title":"Increased gene expression of brown fat uncoupling protein (UCP)1 and skeletal muscle UCP2 and UCP3 in MAC16-induced cancer cachexia","volume":"60","author":"Bing","year":"2000","journal-title":"Cancer Res"},{"key":"R117-20250602","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41586-020-2527-y","article-title":"A leptin-BDNF pathway regulating sympathetic innervation of adipose tissue","volume":"583","author":"Wang","year":"2020","journal-title":"Nature"},{"key":"R118-20250602","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3389\/fimmu.2015.00629","article-title":"Systemic inflammation in cachexia \u2013 Is tumor cytokine expression profile the culprit?","volume":"6","author":"de Matos-Neto","year":"2015","journal-title":"Front Immunol"},{"key":"R119-20250602","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"key":"R120-20250602","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1177\/1534735418781743","article-title":"Lung cancer cachexia: Can molecular understanding guide clinical management?","volume":"17","author":"S\u00f8rensen","year":"2018","journal-title":"Integr Cancer Ther"},{"key":"R121-20250602","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26425","article-title":"Neuroblastoma causes alterations of the intestinal microbiome, gut hormones, inflammatory cytokines, and bile acid composition","volume":"64","author":"Castellani","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R122-20250602","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3390\/nu12072029","article-title":"The effects of prebiotic supplementation with OMNi-LOGiC(\u00ae) FIBRE on fecal microbiome, fecal volatile organic compounds, and gut permeability in murine neuroblastoma-induced tumor-associated cachexia","volume":"12","author":"Oberm\u00fcller","year":"2020","journal-title":"Nutrients"},{"key":"R123-20250602","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13068-018-1106-z","article-title":"Methane-yielding microbial communities processing lactate-rich substrates: A piece of the anaerobic digestion puzzle","volume":"11","author":"Detman","year":"2018","journal-title":"Biotechnol Biofuels"},{"key":"R124-20250602","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature"},{"key":"R125-20250602","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13643-018-0909-0","article-title":"A systematic review of enteric dysbiosis in chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"7","author":"Du Preez","year":"2018","journal-title":"Syst Rev"},{"key":"R126-20250602","doi-asserted-by":"crossref","first-page":"12321","DOI":"10.1038\/s41598-018-30569-5","article-title":"Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction","volume":"8","author":"P\u00f6tgens","year":"2018","journal-title":"Sci Rep"},{"key":"R127-20250602","doi-asserted-by":"crossref","first-page":"18224","DOI":"10.18632\/oncotarget.24804","article-title":"Increased gut permeability in cancer cachexia: Mechanisms and clinical relevance","volume":"9","author":"Bindels","year":"2018","journal-title":"Oncotarget"},{"key":"R128-20250602","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/ismej.2015.209","article-title":"Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia","volume":"10","author":"Bindels","year":"2016","journal-title":"ISME J"},{"key":"R129-20250602","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cell.2017.01.006","article-title":"Pathogen-mediated inhibition of anorexia promotes host survival and transmission","volume":"168","author":"Rao","year":"2017","journal-title":"Cell"},{"key":"R130-20250602","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jcsm.12652","article-title":"Inflammation-induced cholestasis in cancer cachexia","volume":"12","author":"Thibaut","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R131-20250602","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","article-title":"Pleiotropic roles of bile acids in metabolism","volume":"17","author":"de Aguiar Vallim","year":"2013","journal-title":"Cell Metab"},{"key":"R132-20250602","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab"},{"key":"R133-20250602","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm.4392","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat Med"},{"key":"R134-20250602","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.molmed.2017.10.005","article-title":"Targeting obesity and cachexia: Identification of the GFRAL receptor-MIC-1\/GDF15 pathway","volume":"23","author":"Breit","year":"2017","journal-title":"Trends Mol Med"},{"key":"R135-20250602","doi-asserted-by":"crossref","first-page":"e100370","DOI":"10.1371\/journal.pone.0100370","article-title":"The anorectic actions of the TGF\u03b2 cytokine MIC-1\/GDF15 require an intact brainstem area postrema and nucleus of the solitary tract","volume":"9","author":"Tsai","year":"2014","journal-title":"PLoS One"},{"key":"R136-20250602","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/nm1677","article-title":"Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1","volume":"13","author":"Johnen","year":"2007","journal-title":"Nat Med"},{"key":"R137-20250602","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cmet.2020.10.023","article-title":"GDF-15 Neutralization alleviates platinum-based chemotherapy-induced emesis, anorexia, and weight loss in mice and nonhuman primates","volume":"32","author":"Breen","year":"2020","journal-title":"Cell Metab"},{"key":"R138-20250602","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/187152706777452227","article-title":"Growth hormone secretagogue (ghrelin-) receptors \u2013 A complex drug target for the regulation of body weight","volume":"5","author":"Nogueiras","year":"2006","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R139-20250602","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/jcem.87.6.8739","article-title":"The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans","volume":"87","author":"Gnanapavan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R140-20250602","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0053-14.2015","article-title":"Growth hormone secretagogue receptor dimers: A new pharmacological target","volume":"2","author":"Wellman","year":"2015","journal-title":"eNeuro"},{"key":"R141-20250602","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1055\/s-0029-1233462","article-title":"Expression of ghrelin and its receptor in human tissues","volume":"41","author":"Ueberberg","year":"2009","journal-title":"Horm Metab Res"},{"key":"R142-20250602","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI0213300","article-title":"Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity","volume":"109","author":"Shuto","year":"2002","journal-title":"J Clin Invest"},{"key":"R143-20250602","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cmet.2018.02.008","article-title":"The homeostatic force of ghrelin","volume":"27","author":"Yanagi","year":"2018","journal-title":"Cell Metab"},{"key":"R144-20250602","doi-asserted-by":"crossref","first-page":"eaay9592","DOI":"10.1126\/scitranslmed.aay9592","article-title":"Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia","volume":"13","author":"Sartori","year":"2021","journal-title":"Sci Transl Med"},{"key":"R145-20250602","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fendo.2017.00358","article-title":"Osteolytic breast cancer causes skeletal muscle weakness in an immunocompetent syngeneic mouse model","volume":"8","author":"Regan","year":"2017","journal-title":"Front Endocrinol"},{"key":"R146-20250602","doi-asserted-by":"crossref","first-page":"e00075","DOI":"10.1002\/j.2617-1619.2019.tb00011.x","article-title":"Chemotherapy-induced loss of bone and muscle mass in a mouse model of breast cancer bone metastases and cachexia","volume":"2","author":"Hain","year":"2019","journal-title":"JCSM Rapid Commun"},{"key":"R147-20250602","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.immuni.2020.02.017","article-title":"Neuro-immune interactions in the tissues","volume":"52","author":"Chu","year":"2020","journal-title":"Immunity"},{"key":"R148-20250602","doi-asserted-by":"crossref","first-page":"e54095","DOI":"10.7554\/eLife.54095","article-title":"Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer","volume":"9","author":"Burfeind","year":"2020","journal-title":"Elife"},{"key":"R149-20250602","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1158\/1078-0432.CCR-13-1066","article-title":"Prognostic factors in patients with advanced cancer: A comparison of clinicopathological factors and the development of an inflammation-based prognostic system","volume":"19","author":"Laird","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R150-20250602","doi-asserted-by":"crossref","first-page":"820934","DOI":"10.1155\/2015\/820934","article-title":"Potential biomarkers of fat loss as a feature of cancer cachexia","volume":"2015","author":"Ebadi","year":"2015","journal-title":"Mediators Inflamm"},{"key":"R151-20250602","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbalip.2003.12.004","article-title":"Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoprotein","volume":"1636","author":"Russell","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"R152-20250602","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature"},{"key":"R153-20250602","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bjc.6602725","article-title":"Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia","volume":"93","author":"Sanders","year":"2005","journal-title":"Br J Cancer"},{"key":"R154-20250602","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jcsm.12209","article-title":"Circulating activin A predicts survival in cancer patients","volume":"8","author":"Loumaye","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R155-20250602","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.7150\/jca.50376","article-title":"GDF15\/GFRAL Pathway as a metabolic signature for cachexia in patients with cancer","volume":"12","author":"Ahmed","year":"2021","journal-title":"J Cancer"},{"key":"R156-20250602","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: Mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab"},{"key":"R157-20250602","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jcsm.12168","article-title":"Small RNAome profiling from human skeletal muscle: Novel miRNAs and their targets associated with cancer cachexia","volume":"8","author":"Narasimhan","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R158-20250602","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/14737140.2021.1927720","article-title":"A multimodal approach to cancer-related cachexia: From theory to practice","volume":"21","author":"Avancini","year":"2021","journal-title":"Expert Rev Anticancer Ther"},{"key":"R159-20250602","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2009.06.020","article-title":"A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and\/or poor performance non-small cell lung cancer patients (N01C9)","volume":"68","author":"Jatoi","year":"2010","journal-title":"Lung Cancer"},{"key":"R160-20250602","doi-asserted-by":"crossref","first-page":"e102436","DOI":"10.1371\/journal.pone.0102436","article-title":"Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer","volume":"9","author":"Ando","year":"2014","journal-title":"PLoS One"},{"key":"R161-20250602","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","article-title":"A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer","volume":"11","author":"Bayliss","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"R162-20250602","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.clml.2014.12.008","article-title":"Effects of ruxolitinib treatment on metabolic and nutritional parameters in patients with myelofibrosis from COMFORT-I","volume":"15","author":"Mesa","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R163-20250602","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1470-2045(14)70155-X","article-title":"MABp1, a first-in-class true human antibody targeting interleukin-1\u03b1 in refractory cancers: An open-label, phase 1 dose-escalation and expansion study","volume":"15","author":"Hong","year":"2014","journal-title":"Lancet Oncol"},{"key":"R164-20250602","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/0269216312441382","article-title":"Non-steroidal anti-inflammatory drugs for the treatment of cancer cachexia: A systematic review","volume":"27","author":"Reid","year":"2013","journal-title":"Palliat Med"},{"key":"R165-20250602","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/jcsm.12790","article-title":"Long-term, induced expression of Hand2 in peripheral sympathetic neurons ameliorates sarcopenia in geriatric mice","volume":"12","author":"Rodrigues","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R166-20250602","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/2277-9175.179182","article-title":"Pentoxifylline treatment in patients with cancer cachexia: A double-blind, randomized, placebo-controlled clinical trial","volume":"5","author":"Mehrzad","year":"2016","journal-title":"Adv Biomed Res"},{"key":"R167-20250602","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cyto.2005.10.002","article-title":"Erythropoietin attenuates cachectic events and decreases production of interleukin-6, a cachexia-inducing cytokine","volume":"32","author":"Kanzaki","year":"2005","journal-title":"Cytokine"},{"key":"R168-20250602","doi-asserted-by":"crossref","first-page":"djv274","DOI":"10.1093\/jnci\/djv274","article-title":"Preclinical investigation of the novel histone deacetylase inhibitor AR-42 in the treatment of cancer-induced cachexia","volume":"107","author":"Tseng","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"R169-20250602","first-page":"471","article-title":"Interleukin-15 decreases proteolysis in skeletal muscle: A direct effect","volume":"16","author":"Busquets","year":"2005","journal-title":"Int J Mol Med"},{"key":"R170-20250602","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/ijc.26174","article-title":"YC-1 rescues cancer cachexia by affecting lipolysis and adipogenesis","volume":"129","author":"Chung","year":"2011","journal-title":"Int J Cancer"},{"key":"R171-20250602","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.3390\/ijms22168491","article-title":"Cancer cachexia: Its mechanism and clinical significance","volume":"22","author":"Nishikawa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R172-20250602","doi-asserted-by":"crossref","first-page":"e1595","DOI":"10.1212\/WNL.0000000000011626","article-title":"Efficacy and safety of bimagrumab in sporadic inclusion body myositis: Long-term extension of RESILIENT","volume":"96","author":"Amato","year":"2021","journal-title":"Neurology"},{"key":"R173-20250602","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/MCB.01307-13","article-title":"An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy","volume":"34","author":"Lach-Trifilieff","year":"2014","journal-title":"Mol Cell Biol"},{"key":"R174-20250602","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"key":"R175-20250602","doi-asserted-by":"crossref","first-page":"26991","DOI":"10.1038\/srep26991","article-title":"Aerobic exercise and pharmacological treatments counteract cachexia by modulating autophagy in colon cancer","volume":"6","author":"Pigna","year":"2016","journal-title":"Sci Rep"},{"key":"R176-20250602","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/cncr.31128","article-title":"Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04)","volume":"124","author":"Katakami","year":"2018","journal-title":"Cancer"},{"key":"R177-20250602","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/jcsm.12136","article-title":"ACT-ONE - ACTION at last on cancer cachexia by adapting a novel action beta-blocker","volume":"7","author":"Lainscak","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R178-20250602","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1158\/0008-5472.CAN-04-0425","article-title":"Anticachectic effects of formoterol: A drug for potential treatment of muscle wasting","volume":"64","author":"Busquets","year":"2004","journal-title":"Cancer Res"},{"key":"R179-20250602","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/ijc.28128","article-title":"Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia","volume":"133","author":"Murphy","year":"2013","journal-title":"Int J Cancer"},{"key":"R180-20250602","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/bjc.2012.144","article-title":"Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: Selumetinib in patients with cholangiocarcinoma","volume":"106","author":"Prado","year":"2012","journal-title":"Br J Cancer"},{"key":"R181-20250602","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s10637-018-0600-2","article-title":"Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer","volume":"36","author":"Finn","year":"2018","journal-title":"Invest New Drugs"},{"key":"R182-20250602","first-page":"8066","article-title":"Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models","volume":"14","author":"Morimoto","year":"2017","journal-title":"Oncol Lett"},{"key":"R183-20250602","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: A double-blind, randomised controlled phase 2 trial","volume":"14","author":"Dobs","year":"2013","journal-title":"The Lancet. Oncology"},{"key":"R184-20250602","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11912-016-0522-0","article-title":"Study design and rationale for the phase 3 clinical development program of enobosarm, a selective androgen receptor modulator, for the prevention and treatment of muscle wasting in cancer patients (POWER Trials)","volume":"18","author":"Crawford","year":"2016","journal-title":"Curr Oncol Rep"},{"key":"R185-20250602","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1073\/pnas.1402714111","article-title":"Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7","volume":"111","author":"He","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R186-20250602","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13395-021-00274-5","article-title":"Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release","volume":"11","author":"Zhou","year":"2021","journal-title":"Skelet Muscle"},{"key":"R187-20250602","doi-asserted-by":"crossref","first-page":"15347354231168369","DOI":"10.1177\/15347354231168369","article-title":"Babao Dan alleviates cancer cachexia in mice via inhibiting IL-6\/STAT3 signaling pathway","volume":"22","author":"Qiu","year":"2023","journal-title":"Integr Cancer Ther"},{"key":"R188-20250602","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12906-019-2797-9","article-title":"Ginsenoside Rb1 can ameliorate the key inflammatory cytokines TNF-\u03b1 and IL-6 in a cancer cachexia mouse model","volume":"20","author":"Lu","year":"2020","journal-title":"BMC Complement Med Ther"},{"key":"R189-20250602","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jcsm.12675","article-title":"The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: Facts and numbers","volume":"12","author":"Wakabayashi","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:06:45Z","timestamp":1748891205000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":189,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000002846","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"2023-05-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}